Tavapadon Treatment for Early Parkinson Disease

Name: Tavapadon Treatment for Early Parkinson Disease: Findings from the TEMPO Trials
Uploaded: 2026-09-28T04:00:00+00:00
Duration: 16 min 59 s
Description: Hubert Fernandez, MD, Cleveland Clinic, Cleveland, OH, discusses findings from the TEMPO trials evaluating tavapadon, a selective dopamine D1/D5 receptor p

Media formats available:

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Adaptive Deep Brain Stimulation for Parkinson Disease: Patient Selection, Programming, and Practical Considerations
Adaptive Deep Brain Stimulation for Parkinson Disease: Patient Selection, Programming, and Practical Considerations
Movement Disorders
Adaptive Deep Brain Stimulation for Parkinson Disease: Patient Selection, Programming, and Practical Considerations
Pravin Khemani, MD
Pravin Khemani, MD
Wearable Devices in Parkinson Disease: A Practical Guide for Clinicians
Wearable Devices in Parkinson Disease: A Practical Guide for Clinicians
SEP-OCT 2026 ISSUE
Wearable Devices in Parkinson Disease: A Practical Guide for Clinicians
Siegfried Hirczy, MD; Ruth B. Schneider, MD
Siegfried Hirczy, MD; Ruth B. Schneider, MD
Assistive Technology for Communication in Movement Disorders
Assistive Technology for Communication in Movement Disorders
SEP-OCT 2026 ISSUE
Assistive Technology for Communication in Movement Disorders
Nicholas A. Schuck, MD
Nicholas A. Schuck, MD
About the Cover Artist, "Untitled" by Norman Greenstein
About the Cover Artist, "Untitled" by Norman Greenstein
SEP-OCT 2026 ISSUE
About the Cover Artist, "Untitled" by Norman Greenstein